BNTCBenitec Biopharma Inc.
$8.74-37% 1Y
$8.74
$8.7452 weeks$16.52
Latest close: a new 52-week lowOct 8, 2026what changed →
Is it safe?
Watch
2 to watch, 4 without dataCaution warranted: heavy debt (CCC) and big price swings.
Credit gradeCCCderived · Jun 30, 2026
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Drawdown risk64% volderived · Oct 8, 2026
Large price swings, high volatility. Worst drawdown -100% · now 47% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can BNTC take a bad year?
The deepest fall in BNTC's price history on file is −100%; it is 47% below its high today.
−100%
Worst drawdown on file · −47% today
- Annualised volatility
- 64%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $180M
- EBITDA, trailing twelve months
- −$51M
- Operating profit, trailing twelve months
- −$51M
- Annualised volatilitytwo years of daily moves
- 64%
- Worst drawdown on file
- −100%
- Below its 52-week high
- 47%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.